派傑繼續維持對 Immuneering（IMRX）的買入評級
Bratzel covers the Healthcare sector, focusing on stocks such as Abivax SA Sponsored ADR, Argenx Se, and Ardelyx. According to TipRanks, Bratzel has an average return of 52.0% and a 68.52% success rate on recommended stocks. Currently, the analyst consensus on Immuneering is a Strong Buy with an average price target of $15.20, implying a 90.00% upside from current levels. In a report released yesterday, Mizuho Securities also maintained a Buy rating on the stock with a $10.00 price target.
Bratzel covers the Healthcare sector, focusing on stocks such as Abivax SA Sponsored ADR, Argenx Se, and Ardelyx. According to TipRanks, Bratzel has an average return of 52.0% and a 68.52% success rate on recommended stocks.
Currently, the analyst consensus on Immuneering is a Strong Buy with an average price target of $15.20, implying a 90.00% upside from current levels. In a report released yesterday, Mizuho Securities also maintained a Buy rating on the stock with a $10.00 price target.
